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1 INTRODUCTION 
Dendrimers are a novel class of structurally controlled 
macromolecules which have the structure like a tree or 
star shape, with a central core, interior branches and 
terminal groups decorate the surface and from the cavity 
inside the core. Dendrimers have well defined size, 
shape, molecular weight and monodispersity and 
reactivity are determined by generation (shells) and 
chemical composition of the core, interior branching, and 
surface functionalities. It have branched mono-dispersed 
polymer having 5-50 nanometers in diameter with unique 
structural and topological features, by these properties, 
now a day it has considerable interest from both 
scientists and researchers1. Dendrimers are just in 
between molecular chemistry and polymer chemistry. 
Dendrimer oligonucleotide are representative of a new 
segment of polymer science, often been referred to as the 
―Polymers of the 21st century‖. Dendrimer chemistry 
was first introduced in 1978 by Fritz Vogtle and 
coworkers. He synthesized the first ―cascade molecules‖ 
later it was called dendrimer2. The word ―dendrimer‖ 
originated from two words, the Greek word dendron, 
meaning tree, and meros, meaning part. Newkome‘s and 
coworkers independently reported synthesis of similar 
macromolecules. They called them arborols from the 
Latin word ‗arbor‘ also meaning a tree3. Dendritic 
polymers are nanostructures that are suitable for drug 
solubilization applications, delivery of DNA and 
oligonucletide, targeting drug at specific receptor site, 
and ability to act as carrier for the development of drug 
delivery system. Dendrimers are core-shell 
nanostructures with precise architecture and low 
polydispersity, which are synthesized in a layer-by-layer 
fashion (expressed in ‗generations‘) around a core unit, 
resulting in high level of control over size, branching 
points and surface functionality. The ability to tailor 
dendrimer properties to therapeutic needs makes them 
ideal carriers for small molecule drugs and biomolecules. 
Dendrimers are being considered as additives in several 
routes of administration, including intravenous, oral, 
transdermal, pulmonary and ocular
4
. 
2 STRUCTURE OF DENDRIMER 
Dendrimers are built from a starting atom, such as 
nitrogen, to which carbon and other elements are added 
by a repeating series of chemical reactions for the 
production of a spherical branching structure. As the 
process repeats, successive layers are added, and the 
sphere can be expanded to the size required by the 
investigator. The result is a spherical macromolecular 
structure whose size is similar to albumin and 
hemoglobin, but smaller than such multimers as the 
gigantic IgM antibody complex5. The performance of 
these dendrimers are dependent upon its size, generation 
and surface functional groups with increase in dendrimer 
generation the dendrimer, the dendrimer increase linearly 
while the number of surface group increases 
exponentially6 . 
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Figure 1: The Dendrimer Structure 
 
Typical dendrimer are globular nanoscale 
macromolecule with a particular architecture constituted 
of three distinct regions as shown in (Figure.1). 
 An initiator core. 
 Interior layers (generations) composed of repeating 
units, radically attached to the interior core. 
 Exterior (terminal functionality) attached to the 
outermost interior generations. 
3 TYPES OF DENDRIMERS
7, 8
 
 PAMAM Dendrimer monodisperse 
 PPI Dendrimer polymers 
 PAMAMOS Dendrimers 
 Chiral Dendrimer 
 Hybrid Dendrimer 
 Amphiphilic Dendrimer 
 Multilingual Dendrimer 
 Tecto Dendrimer 
 Frechet-Type Dendrimer 
 Peptide Dendrimer 
3.1 PAMAM Dendrimers:  
Synthesis of Poly (amidoamine) dendrimers (PAMAM) 
by the divergent method starting from ethylenediamine 
or ammonia initiator core reagents. Products up to 
generation 10 (a molecular weight of over 9, 30,000 
g/mol) have been obtained (by comparison, the 
molecular weight of human hemoglobin is approximately 
65,000 g/mol). PAMAM dendrimers are commercially 
available, usually as methanol solutions. Trademark 
name is Starburst dendrimers. It is applied as a for a sub-
class of PAMAM dendrimers based on a tris-
aminoethylene-imine core. The name refers to the star 
like pattern observed when looking at the structure of the 
high-generation dendrimers of this type in two- 
dimensions7. 
3.2 PPI /POPAM Dendrimers: 
PPI means Poly (Propylene Frechet-Type Dendrimers: 
These are based on Imine)/Poly (Propylene Amine. 
These dendrimers are generally poly-alkyl amines having 
primary amines as end groups. The dendrimer interior 
consists of numerous of tertiary tris-propylene amines. 
PPI dendrimers are commercially available up to G5, and 
has found widespread applications in material science as 
well as in biology. 
3.3 PAMAMOS Dendrimers: 
Poly (amidoamine-organosilicon) dendrimers 
(PAMAMOS) are inverted unimolecular micelles. It 
consists of hydrophilic, nucleophilic polyamidoamine 
(PAMAM) interiors and hydrophobic organosilicon (OS) 
exteriors.This is useful precursors for the preparation of 
honeycomb-like networks with nanoscopic PAMAM and 
OS domains.   
3.4 Chiral Dendrimer: 
Chiral Dendrimer are commercial dendrimers. These are 
inverted unimolecular based upon the construction of 
constitutionally different micelles that contain exterior 
hydrophobic organosilicon but chemically similar 
branches to chiral core. 
3.5 Hybrid Dendrimer: 
Hybrid dendrimers are combination of dendritic and 
linear polymers in hybrid block or graft copolymer 
forms8. 
3.6 Amphiphilic Dendrimer: 
These are formed by two segregated sites of chain end, 
one half is electron donating and the other half is 
electron withdrawing.  
3.7 Multilingual Dendrimer: 
The surface of these dendrimers contains multiple copies 
of a particular functional group.  
3.8 Tecto Dendrimer: 
These are core dendrimers which is surrounded by other 
dendrimers, each one of which perform a specific varied 
function ranging from diseased cell recognition, 
diagnosis of disease state drug delivery, reporting 
location to reporting outcomes of therapy.  Different 
compounds perform varied functions ranging from 
diseased cell recognition, diagnosis of disease state drug 
delivery, reporting location to reporting outcomes of 
therapy. 
3.9 Frechet-Type Dendrimer: 
It is a more new type of dendrimer formed by Hawker 
and Fréchet based on poly-benzyl ether hyper branched 
skeleton. In the surface of these dendrimers carboxylic 
acid groups are attached. This is serving as a good 
anchoring point for further surface functionalisation, and 
as polar surface groups to increase the solubility of this 
hydrophobic dendrimer type in polar solvents or aqueous 
media. 
3.10 Peptide Dendrimer: 
Peptide dendrimers are those which contain amino acid 
as branching or interior unit. These are used for 
diagnostic purpose and vaccine delivery9. 
4 SYNTHESIS OF DENDRIMERS
8, 10 
Dendrimers are generally prepared using either a 
divergent or a convergent method. There is a 
fundamental difference between these two construction 
methods. 
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4.1 Divergent Method 
In this method, dendrimer develops from a 
multifunctional core molecule. The reaction of core 
molecule with monomer molecules which contains one 
reactive and two dormant groups formed the first 
generation dendrimer. Then this new periphery of first 
generation dendrimer is activated for reactions with more 
monomers. The process is repeated for several 
generations and a dendrimer is built after several layer of 
reaction. Divergent approach is more useful for the 
production of large quantities of dendrimers. Problems 
occur from side reactions and incomplete reactions of the 
end groups that lead to structure defects. To prevent side 
reactions and to force reactions to completion large 
excess of reagents is required. It causes some difficulties 
in the purification of the final product. (Fig.2)                             
4.2 Convergent Method 
The convergent methods were developed as to minimize 
the problems of the divergent synthesis. In the 
convergent approach, the dendrimer is constructed 
stepwise, starting from the end groups (beginning from 
the leaves of the molecular tree) and progressing 
inwards. When the dendrons are developed, they are 
attached to a multifunctional core molecule (Fig. 2). The 
convergent growth method has several advantages. It is 
more suitable to purify the desired product and the 
occurrence of defects in the final structure is minimised. 
By this method introduction of subtle engineering into 
the dendritic structure by precise placement of functional 
groups at the periphery of the macromolecule is possible. 
This approach does not allow the formation of high 
generations because steric problems occur in the 
reactions of the dendrons and the core molecule. 
 
 
Figure 2: Synthetic methods for constructing dendritic macromolecules (Dendrons): (A) the divergent method (B) the 
convergent method. 
 
5 CHARACTERIZATION OF DENDRIMERS
11, 12, 14 
5.1 Spectroscopy technique:  
5.1.1 Nuclear Magnetic Resonance (NMR):  
Nuclear Magnetic Resonance is most widely used for 
characterizing of dendrimers. NMR mainly used for 
analyzing step by step synthesis of dendrimer, to probe 
the size, morphology, dynamic of dendrimers, for 
organic dendrimers such ad PPI, polyphenylester.                    
5.1.2 UV-Visible Spectroscopy:  
UV–Visible spectroscopy can be used to monitor the 
synthesis of dendrimers, as shown for organoplatinum 
dendrimers in which a growth and decay of the metal to 
ligand charge transfer band is observed. The intensity of 
the absorption band is essentially proportional to the 
number of chromophoric units, and can be a test for the 
purity of PPI dendrimers having azobenzene as end 
groups, for phosphorus dendrimers having azobenzenes 
with- in the branches, or double-layered carbosilane 
dendrimers.  
 
5.1.3 Infra-red (IR) and Raman Spectroscopy:  
Infra-red spectroscopy is mainly used for the routine 
analysis of the chemical transformations occurring at the 
surface of dendrimers, such as the disappearance of 
nitrile groups in the synthesis of PPI dendrimers, the 
occurrence of hydrogen bonding in PPI glycine 
functionalized dendrimers, or the disappearance of the 
aldehydes during the synthesis of PMMH dendrimers. 
 5.1.4 Fluorescence:  
The high sensitivity of fluorescence has been used to 
quantify defects during the synthesis of dendrimers, such 
as unreacted CO2H groups in ARB dendrimer, but its 
main use is to characterize the structure of dendrimers 
having photochemical probes covalently linked to one 
particular section.                                                                                 
5.1.5 X-ray diffraction:  
This technique should allow precise determination of the 
chemical composition, size and shape of dendrimers. 
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5.1.6 Mass spectrometry
13
:  
Classical mass spectrometry techniques such as chemical 
ionization or fast atom bombardment (FAB) can be used 
only for the characterization of small dendrimers, whos 
mass is b3000 D. Electro-Spray Ionisation (ESI) can be 
used for dendrimers able to form stable multicharged 
species. It has been applied to PPI dendrimers, and to 
PAMAM dendrimers up to generation 10.  
5.2 Microscopy:  
Transmission electron microscopy and Scanning electron 
microscopy are mainly used for imaging of dendrimers. 
Visualizing single molecules by optical microscopy has 
been successfully carried out for dendrimers having a 
fluorescent core. Confocal microscopy allowed 
observing the fluorescence of a third generation PBzE 
dendrimer having a dihydropyrrolo pyrroledione as a 
core, and of polyphenylene dendrimers having 
peryleneimide as end groups.  
5.3 Size exclusion chromatography (SEC):  
Size Exclusion (or Gel Permeation) Chromatography 
allows the separation of molecules according to size. A 
detector such as a differential refractive index or a LLS 
detector is connected to the SEC apparatus for the 
determination of the polydispersity, which is generally 
very close to unity. Most types of dendrimers were 
characterized by SEC, even self-assembled dendrimers.  
5.4 Electrical techniques:  
5.4.1 Electron Paramagnetic Resonance: Quantitative 
determination of the substitution efficiency on the 
surface of PANAM dendrimers.  
5.4.2 Electrochemistry:  
It gives information about the possibility of interaction of 
electroactive end groups.  
5.4.3 Electrophoresis:  
Used for the assessment of purify and homogeneity of 
several type of water soluble dendrimers.  
5.5 Rheology, physical properties:  
5.5.1 Intrinsic viscosity: Rheology, and particularly 
dilute solution viscosimetry studies, can be used as 
analytical probe of the morphological structure of 
dendrimers. 
5.5.2 Differential Scanning Calorimetry (DSC): 
The DSC technique is generally used to detect the 
glass transition temperature (Tg), which depends on 
the molecular weight, entanglement and chain-end 
composition of polymers. The Tg is affected by the 
end group substitutions, and the molecular mass for 
PBzE dendrimers. 
5.5.3 Dielectric spectroscopy (DS): Dielectric 
spectroscopy gives information about molecular 
dynamic processes in polymers (a-, h-, g-, and y-
relaxation).   
6 APPLICATIONS IN DRUG DELIVERY 
The development of an efficient drug delivery system is 
very important to improve the pharmacokinetic and 
pharmacodynamic activity of drug molecules. 
Dendrimers as carrier have proceeded from as new 
alternatives and efficient tools for delivery of drug 
molecules. As compare to linear polymeric carriers, the 
multivalent functionalities of dendrimers can be linked to 
drug molecules or ligands in a well-defined manner and 
can be used to increase the binding efficiency and 
affinity of therapeutic molecules to receptors via 
synergistic interaction15.   
6.1 Oral drug delivery:  
Oral drug delivery systems are very important and 
convenient and common illnesses are treated via oral 
rout of medication. Dendrimers are biodegradable, and 
capable to hold tha drug with good. By combining the 
ideas of drug carriers and degradability, research has 
recently focused on controlled degradation of dendrimers 
and release of compounds via oral route. Encapsulation 
and conjugation of drug with dendrimers have shown 
immense employment for delivery of hydrophobic and 
labile drugs. Transport of dendrimers throughout 
epithelial part of gastrointestinal tract depends upon its 
characteristics. Anticancer and antihypertensive drugs 
are most promising candidate for oral rout using 
dendrimer as carrier.   
Dendrimers with diameters in the range of 2.5 to 6 nm 
seemed to offer the ideal progression to smaller and 
smaller systems. Problem of flocculation and aggregation 
of the system in vivo, oral uptakes of dendrimers are not 
better as accepted. Using polyoxyethylene glycol chains 
or ionic groups can reduce this problem, but oral uptake 
is then hindered by the hydrophilic nature of the surface 
dendrimers. Dendrimer-drug size, molecular weight, 
surface charge, incubation time and concentration of 
active molecule impart different characteristics for oral 
delivery of dendrimers16.   
6.2 Ocular drug delivery:  
The topical application of active drugs to the eye is the 
most prescribed route of administration for the treatment 
of various ocular disorders. It is generally agreed that the 
intraocular bioavailability of topically applied drugs is 
extremely poor. These results mainly due to drainage of 
the excess fluid via nasolacrimal duct and elimination of 
the solution by tear turnover. Dendrimers provide a 
choice formulation for ocular drug delivery. Recent 
research efforts for improving residence time of 
pilocarpine in the eye was increased by using PAMAM 
dendrimers with carboxylic or hydroxyl surface groups. 
These surface-modified dendrimers were predicted to 
enhance pilocarpine bioavailability17.    
6.3 Transdermal drug delivery: 
Now a day‘s dendrimers have found applications in 
transdermal drug delivery systems. Dendrimers designed 
to be highly water-soluble and biocompatible have been 
shown to be able to improve drug properties such as 
solubility and systemic circulation time via transdermal 
formulations and to deliver drugs efficiently. The 
viscosity imparting property of a dendrimers solution 
allows for ease of handling of highly concentrated 
dendrimer formulations for these applications. 
Dendrimers have been shown to be useful as transdermal 
drug delivery systems for nonsteroidal anti-inflammatory 
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drugs (NSAIDs), antiviral, antimicrobial, anticancer, or 
antihypertensive drugs. PAMAM dendrimers have been 
studied as carrier transdermal systems for the model 
NSAIDs: ketoprofen and diflunisal18.  
6.4 Targeted gene delivery: 
Dendrimers can act as carriers, called vectors, in gene 
therapy. Vectors transfer genes through the cell 
membrane into the nucleus. Currently liposomes and 
genetically engineered viruses have been mainly used for 
this. PAMAM dendrimers have also been tested as 
genetic material carriers. Cationic dendrimers 
(Polypropylenimine (PPI) dendrimer) deliver genetic 
materials into cells by forming complexes with 
negatively charged genetic materials through 
electrostatic interaction. Cationic dendrimers lend 
themselves as non- viral vectors for gene delivery 
because of their ability to form compact complexes with 
DNA. Another potential application could be the use of 
dendrimers coated with sialic acid for the influenza virus 
to attach to the cell surface. In addition, dendrimers are 
non-immunogenic and are thus uniquely suited as carrier 
structures for drugs or bioactive molecules without 
degradation in immune system.   Although the 
application of dendrimers in the field of drug and gene 
delivery is in its infancy compared to liposomes and 
other nanomaterials. Dendrimers are already making an 
impact with the first therapeutic product based on 
dendrimer technology, VivagelTM topical micobicide, 
currently undergoing phase-II trial17, 18. 
6.5 Dendrimers as Solubility Enhancer:  
Dendrimers are unimolecular micellar in nature because 
these have both hydrophobic and hydrophilic layer. 
Hydrophilic layer forms the core and hydrophilic layer 
forms the outer surface. Dendrimers do not have a 
critical micelle concentration. Due to these properties 
dendrimers enhance the solubility of poorly soluble drug 
by forming covalent, non-covalent complexes with drug 
molecules and hydrophobes. 
6.6 Current and Potential Applications of 
Dendrimers
19
:  
 Delivery of Nucleic acids encapsulated drugs and 
covalently linked drugs. 
 Modification of cell-cell interactions and gene 
expression (e.g.: alteration of transcription factors 
binding to DNA). 
 Diagnostic reagents in: serodiagnosis (systems with 
surface ligands), Biosensor systems (systems 
containing dyes, reactive molecules) magnetic 
resonance imaging (e.g.: gadolinium adducts). 
 Dendrimers typically involve conjugating other 
chemical species to the dendrimer surface that can 
function as detecting agents (such as a dye 
molecule), affinity ligands, targeting components, 
radio ligands, imaging agents, or pharmaceutically 
active compounds. 
 New carrier system for drug delivery (gels, self-
associating systems). 
 Vaccines against bacteria, viruses and parasites.  
 Film-forming agents for controlled release. 
 Lubricants for pharmaceutical processing and 
engineering. 
CONCLUSIONS 
Due to their unique structure dendrimers have improved 
physical and chemical properties. These have well 
defined size, shape, molecular weight, monodispersity 
and are unimolecular miceller in nature. These properties 
make the dendrimers a smart choice for drug delivery 
application and enhance the solubility of poorly soluble 
drug. Recent successes in simplifying and optimizing the 
synthesis of dendrimers provide a large variety of 
structures with reduced cost of their production. Also as 
research progresses, newer applications of dendrimers 
will emerge and the future should witness an increasing 
numbers of commercialized dendrimer based drug 
delivery systems. 
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